CAMP FY 2024 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$652,000+86.3% YoY

Gross Profit

$652,000100.0% margin

Operating Income

-$53M-8142.3% margin

Net Income

-$52M-7943.4% margin

EPS (Diluted)

$-2.66

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$78M

Total Liabilities

$15M

Stockholders' Equity

$63M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$652,000	$350,000	+86.3%
Gross Profit	$652,000	$350,000	+86.3%
Operating Income	-$53M	-$52M	-2.3%
Net Income	-$52M	-$49M	-5.1%